Blueprint Medicines and VantAI to advance novel therapies with expanded agreement
The collaboration will focus on induced proximity drug discovery, tackling targets previously deemed “undruggable” by traditional therapeutics
A leading resource for the Pharmaceutical industry since 2002
The collaboration will focus on induced proximity drug discovery, tackling targets previously deemed “undruggable” by traditional therapeutics
Give your business an edge with our leading industry insights.